These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 2296230)
21. Code of fair practices in the promotion of drug products. Md State Med J; 1967 Dec; 16(12):139-40. PubMed ID: 6079133 [No Abstract] [Full Text] [Related]
22. US drug industry's guidelines on advertising too limited, say critics. Burton B BMJ; 2005 Aug; 331(7514):420. PubMed ID: 16110059 [No Abstract] [Full Text] [Related]
23. PAAB: a lesson in self-government. Lexchin J CMAJ; 1991 Apr; 144(7):844-5. PubMed ID: 2007233 [No Abstract] [Full Text] [Related]
25. Drug marketing practices criticized. Wagner L Mod Healthc; 1990 Dec; 20(50):12. PubMed ID: 10108088 [No Abstract] [Full Text] [Related]
26. Capitol Hill panelists want FDA intervention in DTC drug advertising. Med Health; 2005 Oct; 59(36):1, 6, 8. PubMed ID: 16238177 [No Abstract] [Full Text] [Related]
27. Drug firms vow to tone down consumer advertisements. Wadman M Nat Med; 2005 Sep; 11(9):910. PubMed ID: 16145559 [No Abstract] [Full Text] [Related]
28. Misrepresenting an ASHP practice standard for commercial purposes. Myers CE Am J Hosp Pharm; 1994 Sep; 51(17):2107-8. PubMed ID: 7985684 [No Abstract] [Full Text] [Related]
29. Voluntary control of drug promotion in Sweden. Perman E N Engl J Med; 1990 Aug; 323(9):616-7. PubMed ID: 2381456 [No Abstract] [Full Text] [Related]
30. Traveling medicine shows: a modern update? Carroll-Johnson RM Oncol Nurs Forum; 1992 Oct; 19(9):1315. PubMed ID: 1437666 [No Abstract] [Full Text] [Related]
32. Pharmaceutical promotion. Bell KD Med J Aust; 1990 Apr; 152(7):385-6. PubMed ID: 2102687 [No Abstract] [Full Text] [Related]
33. New DTC guidelines please drug companies, anger critics. Med Health; 2005 Aug; 59(27):5-6. PubMed ID: 16111080 [No Abstract] [Full Text] [Related]
34. Rules of conduct and the pharmaceutical industry. Collier J Lancet; 1984 Feb; 1(8374):453. PubMed ID: 6142179 [No Abstract] [Full Text] [Related]
35. Questions timing of publicity on new drug. Dorsey M J Am Vet Med Assoc; 1999 Mar; 214(5):623-4. PubMed ID: 10088006 [No Abstract] [Full Text] [Related]
36. Drug promotion: stealth, wealth, and safety. Lancet; 1993 Jun; 341(8859):1507-8. PubMed ID: 8099382 [No Abstract] [Full Text] [Related]
37. Methodologic quality and relevance of references in pharmaceutical advertisements in a Canadian medical journal. Lexchin J; Holbrook A CMAJ; 1994 Jul; 151(1):47-54. PubMed ID: 8004560 [TBL] [Abstract][Full Text] [Related]
38. Voluntary self-regulatory codes: what should we expect? Lexchin J Am J Bioeth; 2003; 3(3):49-50. PubMed ID: 14594491 [No Abstract] [Full Text] [Related]
39. The advertising of pharmaceutical preparations. WHO Chron; 1969 Jun; 23(6):282-5. PubMed ID: 5793989 [No Abstract] [Full Text] [Related]
40. AAFP supports improvement, not ban, on direct-to-consumer prescription drug ads. Kellerman R; Ann Fam Med; 2007; 5(2):180-1. PubMed ID: 17389544 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]